Can I Take Zinc With Fosamax (Alendronate)?

Why Timing Between Alendronate and Zinc Matters

Alendronate already has one of the lowest oral bioavailabilities of any prescription drug. Under perfect fasting conditions, only about 0.6% of the oral dose reaches systemic circulation. Any substance in the stomach or upper intestine that can chelate (bind) the drug will drive that number even lower. Zinc is one of those substances.

How Chelation Reduces Absorption

Divalent metal cations (zinc²⁺, calcium²⁺, magnesium²⁺, iron²⁺) form insoluble complexes with bisphosphonates in the acidic environment of the stomach [1]. The resulting chelate is too large and too poorly soluble to cross the intestinal epithelium. A 1999 pharmacokinetic study in healthy volunteers demonstrated that co-administration of alendronate with mineral water containing divalent cations reduced alendronate bioavailability by approximately 60% compared to plain water [2].

The Absorption Window Is Narrow

Alendronate is absorbed primarily in the duodenum and upper jejunum within 30 to 60 minutes of ingestion. After that window closes, any drug remaining in the GI lumen passes through without being absorbed. This is why the FDA-approved labeling for Fosamax instructs patients to take the tablet first thing in the morning with 6 to 8 ounces of plain water and wait at least 30 minutes before eating, drinking anything other than water, or taking other medications [3]. Zinc supplements fall squarely into the category of "other medications" for the purpose of this instruction.

This Is Pharmacokinetic, Not Pharmacodynamic

The interaction between zinc and alendronate is pharmacokinetic. Zinc does not alter how alendronate works at the bone surface (its pharmacodynamic target, farnesyl pyrophosphate synthase in osteoclasts). The problem is purely about getting enough drug into the bloodstream. Once alendronate is absorbed and deposited in bone, zinc has no effect on its mechanism of action.

How Zinc Affects Bone Health Independently

Zinc is not just a passive bystander in osteoporosis care. It plays a direct role in bone metabolism, which is part of the reason patients on bisphosphonates often take it.

Zinc and Osteoblast Function

Zinc stimulates osteoblastic bone formation through activation of aminoacyl-tRNA synthetase in osteoblasts and promotes the gene expression of Runx2, a master transcription factor for osteoblast differentiation [4]. In a randomized controlled trial of 60 postmenopausal women, supplementation with 220 mg zinc sulfate (50 mg elemental zinc) twice daily for 90 days produced significant increases in serum osteocalcin, a marker of bone formation, compared to placebo [5].

Zinc Deficiency and Fracture Risk

Population data from the Women's Health Initiative found that women in the lowest quartile of dietary zinc intake had a higher rate of hip fractures compared to those in the highest quartile. A 2020 meta-analysis of seven observational studies (combined N = 205,461) reported that higher zinc intake was associated with a 13% lower risk of osteoporotic fracture (RR 0.87, 95% CI 0.78 to 0.97) [6]. Low serum zinc has also been correlated with lower BMD at the femoral neck and lumbar spine in postmenopausal women [7].

The Copper Balance Issue

Zinc and copper compete for absorption via the same metallothionein pathway. Chronic zinc supplementation above 40 mg/day can deplete copper stores, leading to copper-deficiency anemia and, paradoxically, bone loss. The Tolerable Upper Intake Level (UL) for zinc is 40 mg/day for adults per the NIH Office of Dietary Supplements [8]. Patients on long-term zinc supplementation should have serum copper checked periodically, especially if taking doses above 25 mg elemental zinc daily.

The Correct Way to Take Both

Getting the sequence right is simple once you understand the rule: alendronate goes first, alone, on an empty stomach.

Step-by-Step Dosing Protocol

1. Wake up and take alendronate with 6 to 8 oz of plain water (not mineral water, not sparkling water).
2. Remain upright (sitting or standing) for at least 30 minutes.
3. Do not eat, drink anything besides plain water, or take any supplement during those 30 minutes.
4. After the 30-minute window (60 minutes is better for absorption), eat breakfast and take your zinc supplement with the meal.

Taking zinc with food also reduces the GI side effects of zinc (nausea, metallic taste) and may improve zinc absorption when paired with protein-containing meals [9].

Weekly Alendronate Makes Separation Easier

Most patients take alendronate 70 mg once weekly rather than 10 mg daily. This makes the timing logistics easier to manage. On the six days you are not taking alendronate, zinc timing is irrelevant. On dosing day, follow the sequence above.

What If You Took Them Together?

A single co-ingestion event is unlikely to cause harm, but it may substantially reduce that week's alendronate dose. If you accidentally took zinc and alendronate at the same time, do not take a second alendronate tablet. Wait until your next scheduled dose and resume proper spacing. Report the error to your prescriber if it happens repeatedly, as cumulative under-dosing could reduce fracture protection over time.

Monitoring When Using Both

Patients combining zinc with alendronate should follow standard bisphosphonate monitoring with a few additions.

Bone Mineral Density Tracking

The American Association of Clinical Endocrinologists (AACE) recommends a DXA scan at baseline and repeat every 1 to 2 years during bisphosphonate therapy [10]. If BMD is not improving or is declining despite adherence, one question to ask is whether mineral supplements are interfering with alendronate absorption.

Laboratory Markers

• Serum zinc: check at baseline and annually. Target range is 60 to 120 mcg/dL. Levels below 60 mcg/dL may warrant supplementation increases; levels above 150 mcg/dL suggest excessive intake.
• Serum copper and ceruloplasmin: check if zinc intake exceeds 25 mg/day elemental, or if the patient develops unexplained anemia or neutropenia.
• CTX (C-terminal telopeptide): a bone resorption marker. If alendronate is working, CTX should decrease by 40% or more within 3 to 6 months of starting therapy [11]. Persistently elevated CTX in a patient on alendronate could signal absorption failure from improper supplement timing.
• 25-hydroxyvitamin D: maintain levels above 30 ng/mL, as vitamin D deficiency impairs both calcium absorption and bisphosphonate efficacy [12].

Signs of Copper Depletion to Watch For

Fatigue, pallor, numbness or tingling in the extremities, and frequent infections can all point toward copper deficiency. These symptoms develop gradually over months of excessive zinc intake. A complete blood count showing microcytic or normocytic anemia with low reticulocyte count and neutropenia should prompt a serum copper level.

Which Zinc Form Is Best?

Not all zinc supplements are equivalent in elemental zinc content or absorption characteristics.

Elemental Zinc Content by Form

| Zinc salt | Elemental zinc per dose | Typical tablet | |---|---|---| | Zinc gluconate | 14.3% | 50 mg tablet = 7 mg elemental | | Zinc citrate | 34.2% | 50 mg tablet = 17 mg elemental | | Zinc picolinate | 21.1% | 50 mg capsule = 10.5 mg elemental | | Zinc sulfate | 22.7% | 220 mg capsule = 50 mg elemental |

Absorption Differences

A small crossover study (N = 15) found that zinc picolinate produced significantly higher serum zinc levels than zinc gluconate or zinc citrate over a 4-week supplementation period [13]. Zinc glycinate, a chelated form, may also offer improved bioavailability and fewer GI side effects. For patients on alendronate, the form matters less than the dose and timing. Pick whichever form is tolerated best and maintain the separation window.

Special Populations

Postmenopausal Women

This is the largest group taking both alendronate and zinc. The Endocrine Society's 2019 clinical practice guideline recommends bisphosphonates as first-line pharmacotherapy for postmenopausal osteoporosis in women at high fracture risk [14]. Zinc supplementation in this group is common because dietary intake often falls below the 8 mg/day RDA, particularly in women over 70. A 2015 NHANES analysis estimated that 35% to 45% of older U.S. Adults do not meet the Estimated Average Requirement for zinc from diet alone [15].

Patients on Proton Pump Inhibitors

PPIs reduce gastric acid production, which impairs both alendronate and zinc absorption. Patients on a PPI, alendronate, and zinc face a triple-absorption problem. The 2020 American Gastroenterological Association guideline advises deprescribing PPIs when possible in patients on long-term bisphosphonates [16]. If PPI use is necessary, consider IV zoledronic acid as an alternative bisphosphonate to bypass the GI absorption issue entirely.

Men With Osteoporosis

Alendronate is FDA-approved for osteoporosis in men. The zinc RDA for men (11 mg/day) is higher than for women. Men are more likely to use zinc for testosterone support, and some take doses above 30 mg/day. At these doses, the copper-depletion risk is real. The same dose-separation rules apply regardless of sex.

Zinc, Testosterone, and Bone: The Indirect Link

Zinc plays a role in testosterone synthesis through its action on Leydig cells and its inhibition of aromatase, the enzyme that converts testosterone to estradiol. A well-cited 1996 study by Prasad et al. Showed that dietary zinc restriction in young men reduced serum testosterone by approximately 75% over 20 weeks [17]. This testosterone-zinc relationship has led some men on alendronate to supplement zinc specifically for hormonal support.

The clinical relevance for bone health is indirect. Testosterone promotes bone formation, and severe zinc deficiency can lower testosterone enough to accelerate bone loss. Correcting zinc deficiency may therefore support the skeletal benefits of alendronate in hypogonadal or borderline-hypogonadal men. This does not mean supraphysiologic zinc doses will boost testosterone in zinc-replete individuals. Above-normal zinc intake has not been shown to raise testosterone beyond the physiologic range.

When to Avoid Zinc Supplementation on Alendronate

Zinc supplementation is not appropriate for every patient on alendronate. Avoid or use caution in the following situations:

• Serum zinc is already in the upper normal range (above 100 mcg/dL). Additional supplementation risks copper depletion without benefit.
• Patient is taking copper-chelating medications such as penicillamine or trientine for Wilson disease. Adding zinc on top creates a compounding copper-depletion effect.
• Chronic kidney disease (eGFR below 30 mL/min). Zinc clearance is reduced, and alendronate is contraindicated at this level of renal impairment regardless.
• Patient cannot reliably maintain the dose-separation window. If cognitive impairment, complex medication schedules, or lack of a caregiver makes timing unreliable, the combination may undermine alendronate efficacy. In these cases, consider IV bisphosphonate therapy or a dietitian consult to optimize zinc intake from food sources instead.

The Endocrine Society and AACE guidelines do not specifically recommend or discourage zinc co-supplementation during bisphosphonate therapy. The decision should be individualized based on serum zinc levels, dietary intake, fracture risk, and the patient's ability to maintain proper dosing separation.

Patients taking alendronate 70 mg weekly should separate their zinc dose by at least 30 to 60 minutes, take alendronate first with plain water on an empty stomach, and limit elemental zinc to 40 mg/day or less unless a documented deficiency warrants higher doses under medical supervision.